Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill . Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Abstract

Objective: Cydonia oblonga Mill. leaves ethanolic extract (CydOL-EE) has shown different cardioprotective effects. However, no previous studies investigated its direct effect on the vascular smooth muscle tone. Therefore, the study aimed to test the potential vasodilator activity of CydOL-EE in ex-vivo rat thoracic aorta preparations with an additional investigation of its mechanistic effects. Methods: CydOL-EE phytochemical profile was first investigated by HPLC-DAD-ESI-MS/MS and then tested for the vasorelaxation/vasoreactivity effects in rat aortic rings. The NO synthase inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME) and cyclic guanosine monophosphate inhibitor 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) were used to explore of the involvement of NO-dependent pathways. Results: Chromatographic analysis of CydOL-EE revealed the presence of six flavonols and seven hydroxycinnamic acids. Moreover, CydOL-EE showed a decrease in vasoreactivity caused by dose-dependent phenylephrine (PE) (Control, Emax = 104.29 ± 3.67 vs CydOL-EE, Emax = 70.73 ± 3.67, P < .0001) and a direct relaxing activity to precontraction with PE (Emax = 79.63 ± 3.67%). These responses were abolished during e-NOS inhibition, demonstrating that the mechanism of action was predominately controlled by the participation of an endothelium-dependent system. Conclusion: The results of our study show that CydO-EE demonstrates vasorelaxation and reduction of vasoreactivity through a NO-dependent pathway. These findings provide scientific evidence for further understanding of CydOL-EE use in the treatment of cardiovascular disease.

Keywords

leaves ethanolic extract aorta vasorelaxation vasoreactivity nitric oxide

Introduction

C. oblonga Mill., a member of the Rosaceae family, is primarily grown in the Turkey Region presently, although it originated in the Trans-Caucasus region.¹ Its green, elliptical leaves are 5–10 cm long and have white hairs on the outside.² Based on the phytochemical examination, the main constituents of C. oblonga Mill. were flavonoids, α and β ionol glycosides, organic acids, and phenolic compounds.^3,4 C. oblongata Mill. (CydOL) ethnobotanical uses are in the food industry, culinary uses and medicinal uses for gastrointestinal, respiratory, cardiovascular and infectious diseases.⁵ However CydOL extracts have been demonstrated to have pharmacological properties that are potentially useful in the treatment of diabetes, cough, and bronchitis.^6,7 Additional research using in vitro models demonstrated its antihemolytic and free radical scavenging activity, with IC₅₀ mean values of 30.7 and 24.3 g/mL of methanolic leaf extract,⁸ antibacterial⁹ and antioxidant effects with EC₅₀ mean value of 21.6 µg/mL of ethanolic leaf extract,¹⁰ anticancer activity in renal and colon cells with IC₅₀= 239.7 µg/mL of methanolic leaf extract.¹¹ Additionally, there has been a demonstration in vivo of significant protection against stomach ulcer size and severity, pepsin activity and myeloperoxidase activity of methanolic and aqueous leaf extract,¹² well as in vivo hypolipidemic and hypoglycemic activity or significant reduction of glucose and TC,TG, LDL-C levels with ethanolic leaf and fruit extracts,^13,14 cardioprotective effects⁶ and hypotensive effects in the rat renal hypertensive models and reduction of blood rheology with −27 mm Hg with ethanolic leaf extract.¹⁵ Furthermore, phenolic compounds found in CydOL-EE have demonstrated cardioprotective effects against the metabolic syndrome and its associated diseases, including diabetes, obesity, dyslipidemia, ischemia/reperfusion injury, heart failure, and atherosclerosis, as well as lowering blood pressure and lowering the risk of coronary heart complications through antioxidant and anti-inflammatory properties, as well as by supporting mitochondrial function in cardiac cells.^16-19

However, the CydOL plant extract, such as seeds methanol-aqueous extract (0.003-10 mg/mL) has been demonstrated to have dose-dependent efficacy in releasing in vitro spasms in the ileum (EC₅₀ value of 0.73 mg/mL from ACh and EC50 value of 0.86 mg/mL from KCl) and dilating the in vitro respiratory smooth muscle tone, such as tracheal rings of rabbits (EC value of 0.41 mg/mL from KCl and EC₅₀ value of 0.94 mg/mL from CCh).²⁰

The NO pathway has a very important role in the endothelium-dependent vasorelaxation responses and CVD; therefore endogenous endothelium-dependent NO production lies mainly in the activation of endothelial NO synthase enzyme which activates the cyclic GMP for inducing vascular smooth muscle vasodilation.^21,22 However, there is a lack of previous reports that show the in vitro vasodilatory action of the CydOL-EE and its related mechanistic effects in rat aortic tissue. Therefore, the goal of this study was to perform an investigation of the vasorelaxant effects of CydOL extract and its related endothelium dependent mechanism of action in the isolated rat aorta.

Results and Discussion

CydOL-EE Phytochemical Profile

The CydO-EE (extraction yield 3.8% w/w) phytochemical profile was investigated by HPLC-DAD-ESI-MS/MS. Chromatographic analysis revealed the presence of six flavonols (quercetin 3-O-rutinoside, 3-O-glucoside, 3-O-ramnoside and 3-O-p-coumaroylglucoside, and kaempferol 3-O-rutinoside and 3-O-p-coumaroylglucoside) and seven hydroxycinnamic acids (3-O and 5-O caffeoylquinic and feruloylquinic acids, 4-p-coumaroylquinic acid and p-coumaroylquinic acid isomer, and 3,5-Dicaffeoyl quinic acid). The chemical structures of identified compounds are presented in Figure 1, whereas typical chromatogram obtained at 330 nm and characteristic UV spectra of each class of polyphenolic compounds are presented in Fig S1. Structural characterization data (t_R, UV max, MS data) and content (mg/100 g) of phenolic compounds are presented in Table S1. The results from phytochemical profile and content are in good agreement with those recently reported in the literature by Zhang et al (2021) for C. oblonga leaves methanol extract based on UHPLC-QTOF-MS data.²³

Figure 1.

Chemical structures of 3-O-caffeoyquinic acid (1), 4-O-p-Coumaroylquinic acid isomer (2), 5-O-caffeoylquinic acid (3), 3-O-feruloylquinic acid (4), 4-O-p-coumaroylquinic acid (5), 3,5-O-dicaffeoyl quinic acid (6) quercetin-3-O-rutinoside (7), 5-O-feruloylquinic acid (8), quercetin 3-O-(3′-O-p-coumaroyl)-glucoside (9), quercetin-3-O-glucoside (10), quercetin-3-O-rhamnoside (11), kaempferol 3-O-rutinoside (12) and kaempferol 3-O-(4″-O-p-coumaroyl)-glucoside (13).

Vasorelaxant Effect of CydOL-EE and its Effect on Aortic Vasoreactivity

According to our findings, there was a concentration-dependent relaxing effect (Emax = 79.63 ± 3.67%) for CydOL-EE (0.01-0.1 mg/mL). The inhibition of eNOS and cGMP pathways affected this pharmacological activity; L-NAME + CydOL-EE: Emax = 3.56 ± 0.85%, ODQ + CydOL-EE: Emax = 5.66 ± 0.84%, respectively, contributed to a decrease in the vasorelaxation effect of CydOL-EE (Figure S2A-C, Table S2).

Furthermore, a decrease in vasoreactivity was observed upon incubating tissues with CydOL-EE (0.1 mg/mL), which was found to significantly reduce the maximal effect of the concentration-response curve of cumulative doses of PE (0.01-10 µM) in aortic rings (control Emax = 104.29 ± 3.67 vs CydOL-EE Emax = 70.73 ± 3.67, P < .0001). This demonstrated the antiadrenergic effects of CydOL-EE via alpha-1 adrenergic receptors in the vascular smooth muscle.²⁴ Moreover, eNOS inhibition fully eliminated this response (L-NAME + CydOL-EE: Emax = 113.51 ± 43.50; ODQ + CydOL-EE: Emax = 112.51 ± 2.50) (Figure S3, Table S3). Because the ability of CydOL-EE to dilate blood vessels was completely eliminated by eNOS and cGMP inhibitors, these results clearly demonstrate the endothelium-dependent origin of the observed vasorelaxant effect, which is mediated mainly by the activation of NO pathways. This suggests that endothelium-dependent NO pathways were at play.

A number of studies have shown that CydOL has antihypertensive effects in vivo in renal hypertensive rats¹⁵ and has an effect on blood rheology and rat renal hypertension,¹⁴ lowers hypertension in spontaneously hypertensive rats,²⁵ and lowers systolic, diastolic, and mean arterial pressures in rats and mice,²⁶ there is currently insufficient evidence to support the role of CydOE in direct vascular smooth muscle tone. While reports on non-vascular smooth muscles, such as bronchodilators, antispasmodics, or smooth muscle relaxation in the colon, have only been found in relation to CydO seed extract which has a different chemical profile²⁰ our study provides the first empirical evidence of CydOL-EE's capacity to relax the blood vessels in aortic rings. Phenolic compounds found in CydOL-EE have demonstrated properties that aid in the management and avoidance of vascular disorders.^27-30 The direct vasorelaxant impact that is reliant on the cyclic NO / GMP pathway^31,32 and the decrease in PE-induced contractions, respectively, alpha1 receptors, are further indications of these effects.³³ The results of these investigations corroborate our findings and shed insight on the function and importance of the phytochemicals present in CydOL-EE and partially explain the pharmacological effects of CydOL-EE on cyclic GMP, a vascular tone reliant on the NO pathway.

Experimental

See Supplemental Material.

Conclusions

The results of this study demonstrate that the vasorelaxant action of CydOL-EE is mediated by the endothelium-dependent NO pathway. Taken together, these findings might explain the effects of CydOL-EE on the vascular tone control. Additional in vitro and in vivo investigations are necessary to better distinguish the related mechanism of action beyond that demonstrated in this study. However, this study may pave the way for further investigation on the application of CydOL-EE in vascular tone control.

Supplemental Material

sj-docx-1-npx-10.1177_1934578X241282441 - Supplemental material for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Supplemental material, sj-docx-1-npx-10.1177_1934578X241282441 for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action by Donjeta Krasniqi, Albina Uka, Era Rexhbeqaj, Giangiacomo Beretta, Jasmina Petreska Stanoeva, Bujar Qazimi and Armond Daci in Natural Product Communications

Supplemental Material

sj-docx-2-npx-10.1177_1934578X241282441 - Supplemental material for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Supplemental material, sj-docx-2-npx-10.1177_1934578X241282441 for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action by Donjeta Krasniqi, Albina Uka, Era Rexhbeqaj, Giangiacomo Beretta, Jasmina Petreska Stanoeva, Bujar Qazimi and Armond Daci in Natural Product Communications

Supplemental Material

sj-docx-3-npx-10.1177_1934578X241282441 - Supplemental material for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Supplemental material, sj-docx-3-npx-10.1177_1934578X241282441 for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action by Donjeta Krasniqi, Albina Uka, Era Rexhbeqaj, Giangiacomo Beretta, Jasmina Petreska Stanoeva, Bujar Qazimi and Armond Daci in Natural Product Communications

Supplemental Material

sj-docx-4-npx-10.1177_1934578X241282441 - Supplemental material for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Supplemental material, sj-docx-4-npx-10.1177_1934578X241282441 for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action by Donjeta Krasniqi, Albina Uka, Era Rexhbeqaj, Giangiacomo Beretta, Jasmina Petreska Stanoeva, Bujar Qazimi and Armond Daci in Natural Product Communications

Supplemental Material

sj-docx-5-npx-10.1177_1934578X241282441 - Supplemental material for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action

Supplemental material, sj-docx-5-npx-10.1177_1934578X241282441 for Vasorelaxant Effects of Ethanolic Extract from Cydonia oblonga Mill. Leaves on Isolated Rat Thoracic Aorta and Potential Mechanism of Action by Donjeta Krasniqi, Albina Uka, Era Rexhbeqaj, Giangiacomo Beretta, Jasmina Petreska Stanoeva, Bujar Qazimi and Armond Daci in Natural Product Communications

Footnotes

Acknowledgment

We would like to thank the Ministry of Education, Science, and Technology-Republic of Kosovo, KIKTC, Tempus IV grant and NanoKos for the continued support of our laboratory projects, facilities, and infrastructure in the Faculty of Medicine research units.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical Approval

This study was approved by the Research and Ethics Committee of the Faculty of Medicine at the University of Prishtina, Kosovo (Ref Nr.5181).

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

ORCID iDs

Era Rexhbeqaj

Jasmina Petreska Stanoeva

Armond Daci

Statement of Human and Animal Rights

All the experimental procedures involving animals were conducted in accordance with the Institutional Animal Care Guidelines of University of Prishtina, Kosovo and approved by the Research and Ethics Committee of the Faculty of Medicine at the University of Prishtina, Kosovo (Ref. Nr. 5181)

Statement of Informed Consent

There are no human subjects in this article and informed consent is not applicable.

Supplemental Material

Supplemental material for this article is available online.

References

Al-Snafi

. The medical importance of Cydonia oblonga-A review. IOSR J Pharm. 2016;6(2):87‐99.

Ferreira

de Oliveira

Lopes

Machado

Oliveira

. Potential therapeutic properties of the leaf of cydonia oblonga Mill. based on mineral and organic profiles. Plants (Basel, Switzerland). 2022;11(19):2638. doi:https://doi.org/10.3390/plants11192638

Oliveira

Pereira

Andrade

Valentão

Seabra

Silva

. Phenolic profile of Cydonia oblonge miller leaves. J Agric Food Chem. 2007;55(19):7926‐7930. doi:https://doi.org/10.1021/jf0711237

Oliveira

Pereira

Andrade

Valentão

Seabra

Silva

. Organic acids composition of Cydonia oblonga Miller leaf. Food Chem. 2008;111(2):393‐399. doi:https://doi.org/10.1016/j.foodchem.2008.04.004

Sabir

Qureshi

Arshad

, et al. Pharmacognostic and clinical aspects of Cydonia oblonga: a review. Asian Pacific J Trop Dis. 2015;5(11):850‐855. doi:https://doi.org/10.1016/S2222-1808(15)60934-3

Vaez

Hamidi

Arami

. Potential of Cydonia oblonga leaves in cardiovascular disease. Hypothesis (Macon). 2014;12(1):e4. doi:https://doi.org/10.5779/hypothesis.v12i1.356

Khoubnasabjafari

Jouyban

. A review of phytochemistry and bioactivity of quince (Cydonia oblonga mill.). J Med Plants Res. 2011;5(16):3577‐3594.

Costa

Magalhães

Pereira

, et al. Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: a comparative study with green tea (Camellia sinensis). Food Chem Toxicol. 2009;47(4):860‐865. doi:https://doi.org/10.1016/j.fct.2009.01.019

Cerempei

Mureşan

Cimpoeşu

Carp-Cărare

Rimbu

. Dyeing and antibacterial properties of aqueous extracts from quince (Cydonia oblonga) leaves. Ind Crops Prod. 2016;94(94):216‐225. doi:https://doi.org/10.1016/j.indcrop.2016.08.018

10.

Silva

Andrade

Valentão

Ferreres

Seabra

Ferreira

. Quince (Cydonia oblonga Miller) fruit (pulp, peel, and seed) and jam: antioxidant activity. J Agric Food Chem. 2004;52(15):4705‐4712. doi:https://doi.org/10.1021/jf040057v

11.

Carvalho

Branca

Silva

Valentão

Paula

. First report on cydonia oblonga miller anticancer potential: differential antiproliferative effect against human kidney and colon cancer cells. J Agric Food Chem. 2010;58(6):3366‐3370. doi:https://doi.org/10.1021/jf903836k

12.

Parvan

Sajjadi

Minaiyan

. Protective effect of two extracts of Cydonia oblonga Miller (quince) fruits on gastric ulcer induced by indomethacin in rats. Int J Prev Med. 2017;8(1):58. doi:https://doi.org/10.4103/ijpvm.IJPVM_124_17

13.

Aslan

Orhan

Ergun

. Hypoglycemic activity and antioxidant potential of some medicinal plants traditionally used in Turkey for diabetes. J Ethnopharmacol. 2010;128(2):384‐389. doi:https://doi.org/10.1016/j.jep.2010.01.040

14.

Abliz

Aji

Abdusalam

, et al. Effect of Cydonia oblonga Mill. Leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia. J Ethnopharmacol. 2014;151(2):970‐974. doi:https://doi.org/10.1016/j.jep.2013.12.010

15.

Zhou

Abdusalam

Abliz

, et al. Effect of Cydonia oblonga Mill. Fruit and leaf extracts on blood pressure and blood rheology in renal hypertensive rats. J Ethnopharmacol. 2014;152(3):464‐469. doi:https://doi.org/10.1016/j.jep.2014.01.018

16.

Luo

Shang

. Luteolin: A flavonoid that has multiple cardio-protective effects and its molecular mechanisms. Front Pharmacol. 2017;8(8):692. doi:https://doi.org/10.3389/fphar.2017.00692

17.

Salehi

Venditti

Sharifi-Rad

, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20(6):1305. doi:https://doi.org/10.3390/ijms20061305

18.

Alcázar Magaña

Kamimura

Soumyanath

Stevens

Maier

. Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity. Plant J. 2021;107(5):1299‐1319. doi:https://doi.org/10.1111/tpj.15390

19.

Jan

Khan

Asaf

Lubna Asif

Kim

. Bioactivity and therapeutic potential of kaempferol and quercetin: new insights for plant and human health. Plants (Basel, Switzerland). 2022;11(19):2623. doi:https://doi.org/10.3390/plants11192623

20.

Janbaz

Shabbir

Mehmood

Gilani

. Insight into mechanism underlying the medicinal use of Cydonia oblonga in gut and airways disorders. J Anim Plant Sci. 2013;23(1):330‐336.

21.

Wray

. Calcium signaling in smooth muscle. Handb Cell Signaling, 2/e. 2010;2:1009‐1025. doi:https://doi.org/10.1016/B978-0-12-374145-5.00127-3

22.

Villar

Francis

Webb

Hobbs

Ahluwalia

. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int. 2006;70(5):840‐853. doi:https://doi.org/10.1038/sj.ki.5001680

23.

Zhang

Rocchetti

Zengin

, et al. The UHPLC-QTOF-MS phenolic profiling and activity of Cydonia oblonga Mill. reveals a promising nutraceutical potential. Foods (Basel, Switzerland). 2021;10(6):1230. doi:https://doi.org/10.3390/foods10061230

24.

Xing

Yang

Tang

Wang

. Alpha-1 adrenergic receptor agonist phenylephrine inhibits sepsis-induced cardiomyocyte apoptosis and cardiac dysfunction via activating ERK1/2 signal pathway. Shock. 2019;52(1):122‐133. doi:https://doi.org/10.1097/SHK.0000000000001205

25.

Zhou

Yiming

Mamat

Umar

. Anti-hypertensive effect of total flavonoids of Cydonia oblonga leaves and its mechanism based on anti-inflammatory function. Zhong Yao Cai. 2015;38(10):2134‐2138.

26.

Ur Rahman

Saleem

Alamgeer , et al. Antihypertensive and safety studies of Cydonia oblonga M. Pak J Pharm Sci. 2021;34(2(Supplementary)):687‐691.

27.

Appeldoorn

Venema

Peters

THF

, et al. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J Agric Food Chem. 2009;57(17):7693‐7699. doi:https://doi.org/10.1021/jf901381x

28.

Deliorman

Çaliş

Ergun

Dogan

BSU

Buharalioglu

Kanzik

. Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. J Ethnopharmacol. 2000;72(1-2):323‐329. doi:https://doi.org/10.1016/S0378-8741(00)00251-8

29.

Mocciaro

Bresciani

Tsiountsioura

, et al. Dietary absorption profile, bioavailability of (poly)phenolic compounds, and acute modulation of vascular/endothelial function by hazelnut skin drink. J Funct Foods. 2019;63(May):103576. doi:https://doi.org/10.1016/j.jff.2019.103576

30.

Yousefian

Shakour

Hosseinzadeh

Hayes

Hadizadeh

Karimi

. The natural phenolic compounds as modulators of NADPH oxidases in hypertension. Phytomedicine. 2019;55(55):200‐213. doi:https://doi.org/10.1016/j.phymed.2018.08.002

31.

Lakhanpal

Rai

. Role of quercetin in cardiovascular diseases. Internet J Med Updat - EJOURNAL. 2008;3(1):31‐49. doi:https://doi.org/10.4314/ijmu.v3i1.39858

32.

Massaro

Scoditti

Calabriso

Carluccio

Hugenholtz

De Caterina

. Nutrients and Gene Expression in Cardiovascular Disease. Elsevier Inc.; 2019. doi:https://doi.org/10.1016/B978-0-12-804572-5.00062-8

33.

Choi

Ryu

Park

, et al. Direct vascular actions of quercetin in aorta from renal hypertensive rats. Kidney Res Clin Pract. 2016;35(1):15‐21. doi:https://doi.org/10.1016/j.krcp.2015.12.003

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

0.01 MB

0.36 MB